Ohio Innovation Fund - aVenture Asset Manager Research
Location
Columbus, OH, US
Founded
2016
Ohio Innovation Fund (OIF) is a venture capital firm that partners with visionary founders to shape future industries. The firm primarily invests in early to growth-stage companies, including Seed, Series A, and Series B rounds. OIF focuses on disruptive technologies and innovative solutions across various sectors, with a particular interest in companies that have the potential to create significant market impact.
Notable portfolio companies include Aware, which has raised $84.75 million, and Enable Injections, with $295 million in total funding. OIF has also seen major exits such as ConnXus, acquired by Coupa, and the Continuous Glucose Monitor by Dexcom. The firm offers strategic partnerships and leverages its network to provide value-add services to its portfolio companies. Key decision-makers at OIF bring extensive industry experience and a track record of successful investments.
Ohio Innovation Fund - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
